AMPHASTAR PHARMACEUTICALS IN (AMPH) Stock Cash Flow
NASDAQ:AMPH - Nasdaq - US03209R1032 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 141.63M | 159.52M | 137.54M | 91.39M | 63.30M | |||
| Depreciation Amortization | 58.45M | 57.20M | 41.78M | 25.24M | 23.49M | |||
| Income Taxes - Deferred | N/A | -17.87M | -12.58M | -16.45M | 2.39M | |||
| Change In Working Capital | -24.00M | -14.55M | -24.21M | -32.18M | -1.92M | |||
| Interest Paid | 25.76M | 26.81M | 17.57M | 3.02M | 2.11M | |||
| Taxes Paid | 38.85M | 40.10M | 49.00M | 44.44M | 8.10M | |||
| Other non cash items | 34.96M | 29.08M | 40.97M | 21.18M | 10.74M | |||
| OPERATING CASH FLOW | 193.17M | 213.39M | 183.50M | 89.18M | 97.99M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -42.95M | -41.04M | -38.17M | -24.03M | -27.46M | |||
| Other Investing Activity | -86.74M | -83.89M | -610.95M | -8.74M | -1.22M | |||
| INVESTING CASH FLOW | -129.69M | -124.93M | -649.12M | -32.78M | -28.67M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 7.79M | 10.17M | 526.34M | -1.78M | 32.10M | |||
| Stock Issued/Repurchased | -88.68M | -90.31M | -47.17M | -24.25M | -12.95M | |||
| Other Financing Activity | -986.00K | -816.00K | -25.08M | -410.00K | -56.17M | |||
| FINANCING CASH FLOW | -81.88M | -80.95M | 454.09M | -26.44M | -37.02M | |||
| Exchange Rate Effect | 25.00K | -190.00K | -282.00K | -220.00K | -220.00K | |||
| CHANGE IN CASH | -18.37M | 7.31M | -11.80M | 29.74M | 32.08M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 193.17M | 213.39M | 183.50M | 89.18M | 97.99M | |||
| Capital Expenditure | -42.95M | -41.04M | -38.17M | -24.03M | -27.46M | |||
| FREE CASH FLOW | 150.23M | 172.34M | 145.34M | 65.15M | 70.53M | |||
All data in USD